Gastric Cancer

This study identified salivary biomarkers S100A8, S100A9, CST4, and CST5 as potential tools for early gastric cancer (GC) detection using iTRAQ and PRM proteomics. These biomarkers showed distinct expression patterns and were linked to disease progression, offering a non-invasive, clinically applicable diagnostic approach.